Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Mar 24
 +0.56 / +0.82%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Time to Buy Biotech ETFs?
Mar 13 / Zacks.com - Paid Partner Content


1 month+2.16% 3 years+12.64%
3 months+11.62% 5 years+21.93%
1 year+37.77% Since inception+14.07%
Data through 03/25/2017

Quote Details

Previous close$68.16
Open day’s range68.11 – 69.05
Net asset value (NAV)68.75 (03/24/2017)
Daily volume2,658,296
Average volume (3 months)5,530,709
Data as of 7:59pm ET, 03/24/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+21.93%+16.84%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.821.11
Net assets$3.0B$3.0B
Average market cap$4.9B$30.5B
Average P/E--22.3
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CLVS Clovis Oncology Inc3.22%
KITE Kite Pharma Inc3.13%
ACAD ACADIA Pharmaceuticals Inc2.89%
EXAS Exact Sciences Corp2.83%
INCY Incyte Corp2.69%
EXEL Exelixis Inc2.60%
BLUE bluebird bio Inc2.56%
AMGN Amgen2.50%
ALNY Alnylam Pharmaceuticals Inc2.48%

Search for Jobs